Clinical Context
A patient with a rare or newly approved biologic therapy is scheduled to receive an outpatient infusion or injection billed under the unclassified HCPCS Level II code C9399 when no specific J‑code exists. Typical patients include those with refractory autoimmune diseases, rare hematologic disorders, or oncology indications for which the product is not yet assigned a permanent HCPCS code. The clinical workflow begins with a prescribing clinician (for example, a rheumatologist, hematologist/oncologist, or immunologist) documenting medical necessity and indication in the chart. The drug is obtained by the infusion center or pharmacy and verified by pharmacy staff for dosing and lot information. On the day of service the patient undergoes standard pre‑infusion assessment (vital signs, allergy check), informed consent when required, and administration by an infusion nurse or clinician. Medication preparation, administration time, and any monitoring or complication management (e.g., treatment of infusion reactions, additional observation time) are documented. Billing staff append C9399 with an appropriate modifier (for example, JW for discarded drug, JG is not listed so not used) and include drug name, strength, NDC, quantity, and route on the claim and in supporting documentation. Payer adjudication may require submitted manufacturer invoice, itemized drug receipt, and clinical notes demonstrating medical necessity. Typical sites of service are outpatient hospital infusion centers, physician office infusion suites, and specialty ambulatory infusion clinics. Patient scenario example: a 58‑year‑old with refractory autoimmune hemolytic anemia receives a novel biologic available through limited distribution; the hospital pharmacy prepares the dose, the patient is monitored for two hours post‑infusion for infusion‑related reactions, and the service is billed using C9399 with modifier JW for the portion discarded and modifier 52 if a reduced dose is administered due to tolerance concerns.
Coding Specifications
| Modifier | Description | When to Use |
|---|
JW | Drug amount discarded/not administered to the patient | Use when part of a single‑use vial is discarded and you bill for the amount actually administered; append when required by payer to indicate discard. |
JZ | No drug was administered from the vial | Use when no drug from the prepared vial was administered to the patient and documentation supports zero administration. |
52 | Reduced services | Use when a reduced dose or partial course of the drug is intentionally administered and documentation supports medical necessity for reduction. |
53 | Discontinued procedure | Use when the infusion or administration was started but discontinued for patient safety concerns (e.g., severe reaction). |
59 | Distinct procedural service | Use to indicate a separate and distinct drug administration event or when bundling edits need separation from another service on the same date. |
62 | Two surgeons | Use when two physicians of different specialties are simultaneously required to administer or supervise a complex biologic infusion procedure. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist billing as allowed by state law | Use when an advanced practice clinician performs or supervises the administration per payer rules. |
JW | (See above) | (Avoid duplicate rows; JW is a primary discard modifier commonly required.) |
GZ | Item or service expected to be denied as not reasonable/necessary | Use when the provider documents medical necessity but anticipates denial (no GA signature on file). |
QK | Medical direction of two, three, or four concurrent anesthesia services by one physician | Use only if anesthesia services are required during the administration and the supervising physician directs multiple concurrent anesthetists. |
| Taxonomy Code | Specialty | Notes |
|---|
| 207RH0000X | Hematology & Oncology | Hematologists/oncologists prescribe and oversee biologic therapies for cancer or hematologic disorders. |
| 2080P0207X | Rheumatology | Rheumatologists commonly use biologics for autoimmune and inflammatory diseases requiring infusion services. |
| 363L00000X | Infusion Therapy | Infusion nurses and clinics with this taxonomy manage and administer parenteral biologic agents. |
| 207K00000X | Allergy & Immunology | Allergists/immunologists manage biologic therapies for immune‑mediated conditions and hypersensitivity evaluation. |
| 363A00000X | Pharmacy | Clinical pharmacists manage procurement, compounding, dosing verification, and drug billing details. |
Note: The selected modifier set focuses on discard, reduced or discontinued services, distinct service reporting, and common supervision or practitioner identifiers relevant to C9399 administration.